MediConnect (MEDI) ICO 評価と詳細

ICO

2019年2月20日

2019年4月3日

100% 完成

募集资金 - 无数据

past

Private sale

2019年1月16日

2019年2月6日

100% 完成

募集资金 - 无数据

10 000 000.00 USD

past

令牌详细信息

断续器

MEDI

接受的货币

BTC, STRAT

公司详情

注册国家

United Kingdom

额外细节

KYC

是

分类

平台

关于 MediConnect

患者，处方药，药房和药品制造商的安全网。

由于药房部门的所有监管机构都认识到并担心在线处方药过度处方日益严重的问题，MediConnect几乎可以立即为这一日益严重的问题提供解决方案。

Prescribers＆amp;使用MediConnect的药房将有信心通过使用我们的区块链解决方案，对潜在成瘾者滥用和过度处方处方药＆ndash;谁通常会在网上购买药物＆ndash;将被淘汰。

患者将得到保证，他们正在处方的药物是真实的，并且来自使用黄金标准解决方案的许可制造商，处方医生和药房，以帮助改善他们自己的护理职责。

％name％Roadmap

Q1 2018

Conceived Idea and scoped out requirements of a Prescription Drug Addiction Database.

Q2 2018

Agreed blockchain platform partnership with Stratis.

Q3 2018

Presented idea of a regional trial of East Midlands Pharmacies with newly formed Nottingham Addiction Safeguarding Committee.

Q4 2018

Jason Timms appointed chair of the official Prescription Drug Addiction (PDA) Working Group with the BBFA to tackle over prescribing, drug recalls, counterfeit drug reduction.
Agreed contract start date with ASC Nottingham for Q2 2019 and the onboarding of 2 Pharmacies to MediConnect.
Attended all Chairperson Meeting of the BBFA working groups to look at collaborative opportunities of the PDA on legal, identity, master data, assurance and Cybersecurity working groups.

Q1 2019

ICO Public Sale.
PDA Working Group meeting – Invites to attend to CQC, MHRA, GPhC, LPC, Pharma wholesale and retail industry.

Q2 2019

Commence contract with the ASC to support the Nottingham Trial and UK roll out programme.
Tower Pharmacy & UK Meds will be first 2 Pharmacies on the ASC blockchain solution from MediConnect.
6 other Pharmacies will be integrated, including 1 NHS Hospital outpatient dispensing pharmacy.

Q3 2019

Collaboration with Local Pharmacy Groups and membership committee to inform on pilot and expand reach to 20 further pharmacies in Nottingham, Derby & Leicester.
Partnership with Pharmacy Wholesaler – implementation of drug recall and counterfeit medication system.

Q4 2019

Publish trial research and outcomes – present at PDA meeting to CQC, MHRA. GPhC, LPC and Industry.

Q1 2020

The MediConnect platform will demonstrate an improved duty of care and detection that will see a reduction in pharmacy insurance for Pharmacies.

Q2 2020

Will see the recruitment of 500 UK Pharmacies join MediConnect through the expansion of the ASC membership in the UK.

Q3 2020

Aim for MediConnect to be the Industry standard solution for traceability of drugs for recall and counterfeit medication detection.

Q4 2020

The ASC achieves it’s goal of UK Pharmacies required to be members of the ASC and the MediConnect platform is used by all UK pharmacies